International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 December 2014

Summary

 

IBT Portfolio NAV (m)

208

Number of Portfolio Companies

81

Quoted Investments

56

Unquoted Investments

25

 

Quoted / Unquoted Split
NAV by Geography

Quoted

90%

United States / Canada

89%

Unquoted

10%

Europe

11%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

86%

Large-Cap (>$10bn)

49%

Medical Devices

3%

Mid-Cap (>$1bn, <$10bn)

34%

Specialty Pharma

9%

Small-Cap (<$1bn)

7%

Life Sciences, Tools

2%

Unquoted

9%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

59%

Profitable

57%

Regulatory

13%

Turning Profitable 2014

7%

Phase 3

17%

Unprofitable

36%

Phase 2

7%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%